The research center will focus on developing solutions for manufacturing biopharmaceuticals, including antibodies, recombinant proteins, and viral vectors. It is expected to open in 2027 with 550 employees.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,